REGEN-COV consists of 2 potent, virus-neutralizing antibodies that bind noncompetitively to the receptor binding domain of the SARS-CoV-2 spike protein. The Food and Drug Administration (FDA) has ...
A Public Health Alerts report today details successful administration of intramuscular immunoglobulin (IMIG) as post-exposure ...
Postexposure prophylaxis with bamlanivimab plus etesevimab is not a substitute for vaccination against COVID-19. The Food and Drug Administration (FDA) has expanded the Emergency Use Authorization ...
In a recent study posted to the medRxiv* preprint server, researchers determined evidence for post-exposure vaccination in reducing the mortality rate of coronavirus disease 2019 (COVID-19).
In a study conducted at the University of Washington, USA, the researchers assert that post-exposure prophylaxis with monoclonal antibodies could improve the clinical outcomes and health system costs ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Following the June update that allowed for a lower dose ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. A single subcutaneous dose of Regeneron’s antibody ...
Human immunodeficiency virus (HIV) post-exposure prophylaxis (PEP) entails the prompt administration of antiretroviral agents following potential exposure to prevent viral acquisition. Clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results